Cargando…

Effects of pharmacological and nonpharmacological treatments on brain functional magnetic resonance imaging in Alzheimer’s disease and mild cognitive impairment: a critical review

BACKGROUND: A growing number of pharmacological and nonpharmacological trials have been performed to test the efficacy of approved or experimental treatments in Alzheimer disease (AD) and mild cognitive impairment (MCI). In this context, functional magnetic resonance imaging (fMRI) may be a good can...

Descripción completa

Detalles Bibliográficos
Autores principales: Canu, Elisa, Sarasso, Elisabetta, Filippi, Massimo, Agosta, Federica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819240/
https://www.ncbi.nlm.nih.gov/pubmed/29458420
http://dx.doi.org/10.1186/s13195-018-0347-1
_version_ 1783301173790375936
author Canu, Elisa
Sarasso, Elisabetta
Filippi, Massimo
Agosta, Federica
author_facet Canu, Elisa
Sarasso, Elisabetta
Filippi, Massimo
Agosta, Federica
author_sort Canu, Elisa
collection PubMed
description BACKGROUND: A growing number of pharmacological and nonpharmacological trials have been performed to test the efficacy of approved or experimental treatments in Alzheimer disease (AD) and mild cognitive impairment (MCI). In this context, functional magnetic resonance imaging (fMRI) may be a good candidate to detect brain changes after a short period of treatment. MAIN BODY: This critical review aimed to identify and discuss the available studies that have tested the efficacy of pharmacological and nonpharmacological treatments in AD and MCI cases using task-based or resting-state fMRI measures as primary outcomes. A PubMed-based literature search was performed with the use of the three macro-areas: ‘disease’, ‘type of MRI’, and ‘type of treatment’. Each contribution was individually reviewed according to the Cochrane Collaboration’s tool for assessing risk of bias. Study limitations were systematically detected and critically discussed. We selected 34 pharmacological and 13 nonpharmacological articles. According to the Cochrane Collaboration’s tool for assessing risk of bias, 40% of these studies were randomized but only a few described clearly the randomization procedure, 36% declared the blindness of participants and personnel, and only 21% reported the blindness of outcome assessment. In addition, 28% of the studies presented more than 20% drop-outs at short- and/or long-term assessments. Additional common shortcomings of the reviewed works were related to study design, patient selection, sample size, choice of outcome measures, management of drop-out cases, and fMRI methods. CONCLUSION: There is an urgent need to obtain efficient treatments for AD and MCI. fMRI is powerful enough to detect even subtle changes over a short period of treatment; however, the soundness of methods should be improved to enable meaningful data interpretation.
format Online
Article
Text
id pubmed-5819240
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58192402018-02-21 Effects of pharmacological and nonpharmacological treatments on brain functional magnetic resonance imaging in Alzheimer’s disease and mild cognitive impairment: a critical review Canu, Elisa Sarasso, Elisabetta Filippi, Massimo Agosta, Federica Alzheimers Res Ther Review BACKGROUND: A growing number of pharmacological and nonpharmacological trials have been performed to test the efficacy of approved or experimental treatments in Alzheimer disease (AD) and mild cognitive impairment (MCI). In this context, functional magnetic resonance imaging (fMRI) may be a good candidate to detect brain changes after a short period of treatment. MAIN BODY: This critical review aimed to identify and discuss the available studies that have tested the efficacy of pharmacological and nonpharmacological treatments in AD and MCI cases using task-based or resting-state fMRI measures as primary outcomes. A PubMed-based literature search was performed with the use of the three macro-areas: ‘disease’, ‘type of MRI’, and ‘type of treatment’. Each contribution was individually reviewed according to the Cochrane Collaboration’s tool for assessing risk of bias. Study limitations were systematically detected and critically discussed. We selected 34 pharmacological and 13 nonpharmacological articles. According to the Cochrane Collaboration’s tool for assessing risk of bias, 40% of these studies were randomized but only a few described clearly the randomization procedure, 36% declared the blindness of participants and personnel, and only 21% reported the blindness of outcome assessment. In addition, 28% of the studies presented more than 20% drop-outs at short- and/or long-term assessments. Additional common shortcomings of the reviewed works were related to study design, patient selection, sample size, choice of outcome measures, management of drop-out cases, and fMRI methods. CONCLUSION: There is an urgent need to obtain efficient treatments for AD and MCI. fMRI is powerful enough to detect even subtle changes over a short period of treatment; however, the soundness of methods should be improved to enable meaningful data interpretation. BioMed Central 2018-02-20 /pmc/articles/PMC5819240/ /pubmed/29458420 http://dx.doi.org/10.1186/s13195-018-0347-1 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Canu, Elisa
Sarasso, Elisabetta
Filippi, Massimo
Agosta, Federica
Effects of pharmacological and nonpharmacological treatments on brain functional magnetic resonance imaging in Alzheimer’s disease and mild cognitive impairment: a critical review
title Effects of pharmacological and nonpharmacological treatments on brain functional magnetic resonance imaging in Alzheimer’s disease and mild cognitive impairment: a critical review
title_full Effects of pharmacological and nonpharmacological treatments on brain functional magnetic resonance imaging in Alzheimer’s disease and mild cognitive impairment: a critical review
title_fullStr Effects of pharmacological and nonpharmacological treatments on brain functional magnetic resonance imaging in Alzheimer’s disease and mild cognitive impairment: a critical review
title_full_unstemmed Effects of pharmacological and nonpharmacological treatments on brain functional magnetic resonance imaging in Alzheimer’s disease and mild cognitive impairment: a critical review
title_short Effects of pharmacological and nonpharmacological treatments on brain functional magnetic resonance imaging in Alzheimer’s disease and mild cognitive impairment: a critical review
title_sort effects of pharmacological and nonpharmacological treatments on brain functional magnetic resonance imaging in alzheimer’s disease and mild cognitive impairment: a critical review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819240/
https://www.ncbi.nlm.nih.gov/pubmed/29458420
http://dx.doi.org/10.1186/s13195-018-0347-1
work_keys_str_mv AT canuelisa effectsofpharmacologicalandnonpharmacologicaltreatmentsonbrainfunctionalmagneticresonanceimaginginalzheimersdiseaseandmildcognitiveimpairmentacriticalreview
AT sarassoelisabetta effectsofpharmacologicalandnonpharmacologicaltreatmentsonbrainfunctionalmagneticresonanceimaginginalzheimersdiseaseandmildcognitiveimpairmentacriticalreview
AT filippimassimo effectsofpharmacologicalandnonpharmacologicaltreatmentsonbrainfunctionalmagneticresonanceimaginginalzheimersdiseaseandmildcognitiveimpairmentacriticalreview
AT agostafederica effectsofpharmacologicalandnonpharmacologicaltreatmentsonbrainfunctionalmagneticresonanceimaginginalzheimersdiseaseandmildcognitiveimpairmentacriticalreview